Generic Oncology Drugs Market Size, Share, And Growth Report 2032
Generic Oncology Drugs Market by Molecule (Large and Small), by Administration Route (Oral and Parenteral), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 26.09 Billion | USD 44.83 Billion | 6.2% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Generic Oncology Drugs market, 2017-2025 (USD Million)
- 2.2. Global Generic Oncology Drugs Market: Snapshot
- Chapter 3. Global Generic Oncology Drugs Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Cancer Incidences
- 3.2.2. Growing R&D Spending
- 3.2.3. Favorable Reimbursement Scenario in Developed Countries
- 3.2.4. Increasing demand for Generic Oncology Drugs
- 3.3. Market Restraints
- 3.3.1. Side Effects of Cancer Drugs
- 3.3.2. Low Affordability in Developing Countries
- 3.3.3. Low Awareness about Generic Oncology Drugs
- 3.4. Opportunities
- 3.4.1. Strategic Alliances formed by Generic Oncology Drugs Companies
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis, by Molecule
- 3.6.2. Market attractiveness analysis, by Administration Route
- 3.6.3. Market attractiveness analysis, by Distribution Channel
- 3.6.4. Market attractiveness analysis, by region
- Chapter 4. Global Generic Oncology Drugs Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Generic Oncology Drugs Market: Company Market Share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New therapy launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Generic Oncology Drugs Market - Molecule analysis
- 5.1. Global Generic Oncology Drugs Market: Molecule overview
- 5.1.1. Global Generic Oncology Drugs Market Revenue Share, by Molecule, 2018 and 2025
- 5.2. Large Molecule
- 5.2.1. Global Generic Oncology Drugs Market for Large Molecule, 2017-2025 (USD Million)
- 5.3. Small Molecule
- 5.3.1. Global Generic Oncology Drugs Market for Small Molecule, 2017-2025 (USD Million)
- 5.1. Global Generic Oncology Drugs Market: Molecule overview
- Chapter 6. Global Generic Oncology Drugs Market - Administration Route Analysis
- 6.1. Global Generic Oncology Drugs Market: Administration Route
- 6.1.1. Global Generic Oncology Drugs Market Revenue Share, by Administration Route, 2018 and 2025
- 6.2. Oral
- 6.2.1. Global Generic Oncology Drugs Market for Oral, 2017-2025 (USD Million)
- 6.3. Parenteral
- 6.3.1. Global Generic Oncology Drugs Market for Parenteral, 2017-2025 (USD Million)
- 6.1. Global Generic Oncology Drugs Market: Administration Route
- Chapter 7. Global Generic Oncology Drugs Market - Distribution Channel Analysis
- 7.1. Global Generic Oncology Drugs Market Distribution Channel
- 7.1.1. Global Generic Oncology Drugs Market Revenue Share, by Distribution Channel, 2018 and 2025
- 7.2. Hospital Pharmacy
- 7.2.1. Global Generic Oncology Drugs Market for Hospital Pharmacy, 2017-2025 (USD Million)
- 7.3. Retail Pharmacy
- 7.3.1. Global Generic Oncology Drugs Market for Retail Pharmacy, 2017-2025 (USD Million)
- 7.4. Online Pharmacy
- 7.4.1. Global Generic Oncology Drugs Market for Online Pharmacy, 2017-2025 (USD Million)
- 7.1. Global Generic Oncology Drugs Market Distribution Channel
- Chapter 8. Global Generic Oncology Drugs Market - Regional Analysis
- 8.1. Global Generic Oncology Drugs Market: Regional Overview
- 8.1.1. Global Generic Oncology Drugs Market Revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.2.2. North America Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.2.3. North America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.2.4.2. The U.S. Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.2.4.3. The U.S. Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.2.5.2. Rest of North America Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.2.5.3. Rest of North America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.3.2. Europe Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.3.3. Europe Generic Oncology Drugs Market Revenue, by End -User, 2017-2025 (USD Million)
- 8.3.4. UK
- 8.3.4.1. UK Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.3.4.2. UK Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.3.4.3. UK Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3.5. Germany
- 8.3.5.1. Germany Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.3.5.2. Germany Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.3.5.3. Germany Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.3.6.2. France Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.3.6.3. France Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.3.7.2. Rest of Europe Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.3.7.3. Rest of Europe Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.4.2. Asia Pacific Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.4.3. Asia Pacific Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.4. China
- 8.4.4.1. China Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.4.4.2. China Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.4.4.3. China Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.4.5.2. Japan Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.4.5.3. Japan Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. India Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.4.6.2. India Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.4.6.3. India Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.4.7.2. Rest of Asia Pacific Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.4.7.3. Rest of Asia Pacific Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.5.2. Latin America Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.5.3. Latin America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.5.4.2. Brazil Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.5.4.3. Brazil Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.5.5.2. Rest of Latin America Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.5.5.3. Rest of Latin America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Generic Oncology Drugs Market Revenue, by Molecule, 2017-2025 (USD Million)
- 8.6.2. The Middle East and Africa Generic Oncology Drugs Market Revenue, by Administration Route, 2017-2025 (USD Million)
- 8.6.3. The Middle East and Africa Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017-2025 (USD Million)
- 8.1. Global Generic Oncology Drugs Market: Regional Overview
- Chapter 9. Company Profile
- 9.1. Amgen
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Molecule portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Bayer Healthcare
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Molecule portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Teva Pharmaceutical Industries
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Molecule portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Boehringer Ingelheim
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Molecule portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Pfizer
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Molecule portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. AstraZeneca
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Molecule portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Eli Lily and Company
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Molecule portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Hoffmann-La Roche
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Molecule portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. ARIAD Pharmaceuticals
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Molecule portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. CELGENE Corporation
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Molecule portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.11. GlaxoSmithKline
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Molecule portfolio
- 9.11.4. Business strategy
- 9.11.5. Recent developments
- 9.12. Novartis
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Molecule portfolio
- 9.12.4. Business strategy
- 9.12.5. Recent developments
- 9.13. Johnson and Johnson
- 9.13.1. Overview
- 9.13.2. Financials
- 9.13.3. Molecule portfolio
- 9.13.4. Business strategy
- 9.13.5. Recent developments
- 9.14. Merck
- 9.14.1. Overview
- 9.14.2. Financials
- 9.14.3. Molecule portfolio
- 9.14.4. Business strategy
- 9.14.5. Recent developments
- 9.1. Amgen
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Generic Oncology Drugs Market Revenue, 2017–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Generic Oncology Drugs Market attractiveness analysis, by Molecule
6. Global Generic Oncology Drugs Market attractiveness analysis, by Administration Route
7. Global Generic Oncology Drugs Market attractiveness analysis, by Distribution Channel
8. Global Generic Oncology Drugs Market attractiveness analysis, by region
9. Company market share analysis, 2019
10. Global Generic Oncology Drugs Market Revenue Share by Molecule, 2018 and 2025
11. Global Generic Oncology Drugs Market Revenue Share by Large Molecule, 2017–2025 (USD Million)
12. Global Generic Oncology Drugs Market Revenue Share by Small Molecule, 2017–2025 (USD Million)
13. Global Generic Oncology Drugs Market Revenue Share by Administration Route, 2018 and 2025
14. Global Generic Oncology Drugs Market Revenue Share by Oral, 2017–2025 (USD Million)
15. Global Generic Oncology Drugs Market Revenue Share by Parenteral, 2017–2025 (USD Million)
16. Global Generic Oncology Drugs Market Revenue Share by Distribution Channel, 2017–2025 (USD Million)
17. Global Generic Oncology Drugs Market Revenue Share by Hospital Pharmacy, 2017–2025 (USD Million)
18. Global Generic Oncology Drugs Market Revenue Share by Retail Pharmacy, 2017–2025 (USD Million)
19. Global Generic Oncology Drugs Market Revenue Share by Online Pharmacy, 2017–2025 (USD Million)
Table Of Tables
List of Tables
1. Global Generic Oncology Drugs Market: Market Snapshot
2. Drivers of the Global Generic Oncology Drugs Market: Impact Analysis
3. Restraints of the Global Generic Oncology Drugs Market: Impact Analysis
4. North America Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
5. North America Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
6. North America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
7. The U.S. Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
8. The U.S. Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
9. The U.S. Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
10. Rest of North America Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
11. Rest of North America Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
12. Rest of North America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
13. Europe Global Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
14. Europe Global Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
15. Europe Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
16. UK Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
17. UK Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
18. UK Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
19. Germany Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
20. Germany Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
21. Germany Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
22. France Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
23. France Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
24. France Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
25. Rest of Europe Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
26. Rest of Europe Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
27. Rest of Europe Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
28. Asia Pacific Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
29. Asia Pacific Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
30. Asia Pacific Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
31. China Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
32. China Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
33. China Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
34. Japan Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
35. Japan Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
36. Japan Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
37. India Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
38. India Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
39. India Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
40. Rest of Asia Pacific Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
41. Rest of Asia Pacific Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
42. Rest of Asia Pacific Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
43. Latin America Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
44. Latin America Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
45. Latin America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
46. Brazil Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
47. Brazil Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
48. Brazil Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
49. Rest of Latin America Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
50. Rest of Latin America Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
51. Rest of Latin America Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
52. The Middle East and Africa Generic Oncology Drugs Market Revenue, by Molecule, 2017–2025 (USD Million)
53. The Middle East and Africa Generic Oncology Drugs Market Revenue, by Administration Route, 2017–2025 (USD Million)
54. The Middle East and Africa Generic Oncology Drugs Market Revenue, by Distribution Channel, 2017–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Generic oncology drugs are medications used to treat cancer that are equivalent to brand-name drugs in dosage, safety, strength, quality, and intended use, but are typically offered at a lower cost.
According to study, the Generic Oncology Drugs Market size was worth around USD 26.09 billion in 2023 and is predicted to grow to around USD 44.83 billion by 2032.
The CAGR value of Generic Oncology Drugs Market is expected to be around 6.2% during 2024-2032.
Asia Pacific has been leading the Generic Oncology Drugs Market and is anticipated to continue on the dominant position in the years to come.
The Generic Oncology Drugs Market is led by players like Amgen, Bayer Healthcare, Teva Pharmaceutical, Boehringer Ingelheim, Pfizer, AstraZeneca, Eli Lily and Company, Hoffmann-La Roche, ARIAD Pharmaceuticals, CELGENE Corporation, GlaxoSmithKline, Novartis, Johnson and Johnson, Merck, AbbVie, and Sanofi.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed